Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

PMBC's offer high survival and recovery rates

publication date: Jul 25, 2012
 | 
author/source: AMS Biotechnology
AMSBIO has introduced the ImmunoPureTM range of peripheral blood mononuclear cells (PBMCs) supplied in proprietary reagents that ensure high survival and recovery rates.

amsbioImmunoPureTM PBMCs are a variety of immune cells derived from the peripheral blood of normal healthy human adult donors collected at IRB-approved blood banks.  Seven types are currently available and consist of a variety of immune cells derived from the peripheral blood of normal adults, thereby qualifying them for a diverse number of cell-based experiments. The lymphocyte and monocyte fractions are isolated from whole blood using apheresis, a technology in which the blood of a donor is passed through an apparatus that separates out these fractions, and returns the remainder to the donor's circulation. After depletion of granulocytes, and red blood cell these PBMCs are immediately cryopreserved using proprietary reagents to ensure high cell viability. All cell batches of ImmunoPureTM PBMCs are rigorously tested to be free from infectious agents and analysed for cell viability, cell purity, cell count, and CD markers.

ImmunoPureTM PBMCs the latest addition to a comprehensive collection of primary cells supplied by AMSBIO that represent a diverse and heterogeneous population of donors.  As well as a variety of normal human primary cells offered with optimized media, AMSBIO offer viable primary tumour cells from a huge number of cancer types.


For further information on ImmunoPureTM peripheral blood mononuclear cells (PBMCs) please click here  or contact AMSBIO on +44-1235-828200 or email info@amsbio.com.


Founded in 1987, AMS Biotechnology (AMSBIO) is recognised as a leading international provider of unique, innovative products & custom services for life sciences research. The AMSBIO range includes over 23,000 polyclonal &monoclonal antibodies, peptides, recombinant proteins, extracellular matrix, molecular detection reagents, & tissue DNA, RNA, protein & microarray products. Key research areas include: apoptosis, cell invasion & migration, cell signaling, DNA damage, 3D culture, electrophoresis, glycobiology, post-translational modification & stem cell biology.


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners